BRAF and uveal melanoma: Despite this apparent lack of the characteristic BRAF mutation, inappropriate downstream MAPK component activation has been reported by Weber et al (2003) who failed to identify the BRAF mutation in 42 primary uveal melanoma but showed immunohistochemical staining for ERK in 86% of these cases.